233 related articles for article (PubMed ID: 33728733)
1. Publication Bias in Gastrointestinal Oncology Trials Performed over the Past Decade.
Peters GW; Tao W; Wei W; Miccio JA; Jethwa KR; Cecchini M; Johung KL
Oncologist; 2021 Aug; 26(8):660-667. PubMed ID: 33728733
[TBL] [Abstract][Full Text] [Related]
2. Disparities in positive results and dissemination of randomized controlled trials in immuno-oncology.
Xu C; Zhang S; Zhu GL; Yang KB; Zhang Y; Mao YP; Tang LL; Liu Q; Huang Y; Ma J
Int Rev Immunol; 2023; 42(2):91-100. PubMed ID: 35712868
[TBL] [Abstract][Full Text] [Related]
3. Detecting the Dark Matter of Unpublished Clinical Cancer Studies: An Analysis of Phase 3 Randomized Controlled Trials.
Pasalic D; Fuller CD; Mainwaring W; Lin TA; Miller AB; Jethanandani A; Espinoza AF; Grossberg AJ; Jagsi R; Das P; Koong AC; Rödel C; Fokas E; Thomas CR; Minsky BD; Ludmir EB
Mayo Clin Proc; 2021 Feb; 96(2):420-426. PubMed ID: 33549260
[TBL] [Abstract][Full Text] [Related]
4. Time to publication of oncology trials and why some trials are never published.
Chapman PB; Liu NJ; Zhou Q; Iasonos A; Hanley S; Bosl GJ; Spriggs DR
PLoS One; 2017; 12(9):e0184025. PubMed ID: 28934243
[TBL] [Abstract][Full Text] [Related]
5. Preliminary evaluation of factors associated with premature trial closure and feasibility of accrual benchmarks in phase III oncology trials.
Schroen AT; Petroni GR; Wang H; Gray R; Wang XF; Cronin W; Sargent DJ; Benedetti J; Wickerham DL; Djulbegovic B; Slingluff CL
Clin Trials; 2010 Aug; 7(4):312-21. PubMed ID: 20595245
[TBL] [Abstract][Full Text] [Related]
6. Discontinuation and nonpublication of clinical trials in orthopaedic oncology.
Singh G; Wague A; Arora A; Rao V; Ward D; Barry J
J Orthop Surg Res; 2024 Feb; 19(1):121. PubMed ID: 38317223
[TBL] [Abstract][Full Text] [Related]
7. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
8. Unpublished completed obstetric randomized clinical trials registered at ClinicalTrials.gov: how big is this issue?
Gupta M; Oliver EA; Chauhan SP; Wagner SM; Mol B; Berghella V
Am J Obstet Gynecol MFM; 2023 Sep; 5(9):101066. PubMed ID: 37419451
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with failure to publish large randomized trials presented at an oncology meeting.
Krzyzanowska MK; Pintilie M; Tannock IF
JAMA; 2003 Jul; 290(4):495-501. PubMed ID: 12876092
[TBL] [Abstract][Full Text] [Related]
10. Publication status of contemporary oncology randomised controlled trials worldwide.
Chen YP; Liu X; Lv JW; Li WF; Zhang Y; Guo Y; Lin AH; Sun Y; Mao YP; Ma J
Eur J Cancer; 2016 Oct; 66():17-25. PubMed ID: 27522246
[TBL] [Abstract][Full Text] [Related]
11. Association of trial registration with the results and conclusions of published trials of new oncology drugs.
Rasmussen N; Lee K; Bero L
Trials; 2009 Dec; 10():116. PubMed ID: 20015404
[TBL] [Abstract][Full Text] [Related]
12. Lack of timely accrual information in oncology clinical trials: a cross-sectional analysis.
Mitchell AP; Hirsch BR; Abernethy AP
Trials; 2014 Mar; 15():92. PubMed ID: 24661848
[TBL] [Abstract][Full Text] [Related]
13. Noncompletion and nonpublication of trials studying rare diseases: A cross-sectional analysis.
Rees CA; Pica N; Monuteaux MC; Bourgeois FT
PLoS Med; 2019 Nov; 16(11):e1002966. PubMed ID: 31751330
[TBL] [Abstract][Full Text] [Related]
14. Rates of Discontinuation and Nonpublication of Head and Neck Cancer Randomized Clinical Trials.
Johnson AL; Fladie I; Anderson JM; Lewis DM; Mons BR; Vassar M
JAMA Otolaryngol Head Neck Surg; 2020 Feb; 146(2):176-182. PubMed ID: 31876933
[TBL] [Abstract][Full Text] [Related]
15. Discontinuation and nonpublication of pediatric otolaryngology clinical trials.
Johnson AL; Torgerson T; Adewumi MT; Kee M; Farahani C; Wehrmann DJ; Francis CL; Vassar M
Int J Pediatr Otorhinolaryngol; 2021 Dec; 151():110972. PubMed ID: 34773883
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and Research Waste Among Randomized Clinical Trials in Gastric Cancer.
Lu J; Xu BB; Shen LL; Wu D; Xue Z; Zheng HL; Xie JW; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Huang CM; Zheng CH; Li P
JAMA Netw Open; 2021 Sep; 4(9):e2124760. PubMed ID: 34533573
[TBL] [Abstract][Full Text] [Related]
17. Creating and Implementing a Principal Investigator Tool Kit for Enhancing Accrual to Late Phase Clinical Trials: Development and Usability Study.
Higgins KA; Thomas A; Soto N; Paulus R; George TJ; Julian TB; Hartson Stine S; Markham MJ; Werner-Wasik M
JMIR Cancer; 2022 Aug; 8(3):e38514. PubMed ID: 36006678
[TBL] [Abstract][Full Text] [Related]
18. Early Termination of Oncology Clinical Trials in the United States.
Zhang E; DuBois SG
Cancer Med; 2023 Mar; 12(5):5517-5525. PubMed ID: 36305832
[TBL] [Abstract][Full Text] [Related]
19. Assessing the Eventual Publication of Clinical Trial Abstracts Submitted to a Large Annual Oncology Meeting.
Massey PR; Wang R; Prasad V; Bates SE; Fojo T
Oncologist; 2016 Mar; 21(3):261-8. PubMed ID: 26888691
[TBL] [Abstract][Full Text] [Related]
20. Selective Publication within Vascular Surgery: Characteristics of Discontinued and Unpublished Randomized Clinical Trials.
Binko MA; Reitz KM; Chaer RA; Haga LM; Go C; Alie-Cusson FS; Tzeng E; Eslami MH; Sridharan ND
Ann Vasc Surg; 2023 Sep; 95():251-261. PubMed ID: 37311508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
